ASRT | Assertio Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.2100 - 1.2500
52 Week Range	0.7300 - 2.7600
Beta	0.83
Implied Volatility	526.70%
IV Rank	25.04%
Day's Volume	350,497
Average Volume	1,133,630
Shares Outstanding	95,335,600
Market Cap	118,216,144
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	1997-12-03

Valuation
Profitability
Growth
Health
P/E Ratio	-0.26
Forward P/E Ratio	15.13
EPS	-4.85
1YR Price Target	10.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	53
Country	USA
Website	ASRT

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

ASRT's peers: AMRX, AGRX, ACRX, LFCR, IRWD, NBIX, DCPH, ESPR, ANIP, ALKS, RDY, COLL, PCRX, ITCI, CTLT, AMPH, ALVO, EGRX, EOLS, AVDL, CYTH, ZTS

*Chart delayed

Analyzing fundamentals for ASRT we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see ASRT Fundamentals page.

Watching at ASRT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ASRT Technicals page.